Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial protein thiol groups, specifically the sulfhydryl (-SH) side chains of cysteine residues, are critical components of the bacterial proteome. They play essential roles in enzymatic catalysis, where they often serve as nucleophiles, and in maintaining the redox balance of the cell through molecules like glutathione or mycothiol (Antioxidants & Redox Signaling, 2014). Furthermore, thiols are vital for the structural stability of proteins via the formation of disulfide bonds, particularly in the periplasmic space of Gram-negative bacteria (Nature Reviews Microbiology, 2009). Many antimicrobial agents, particularly heavy metals like silver and oxidizing agents like hypochlorous acid, exert their effects by binding to or oxidizing these thiol groups, leading to widespread protein denaturation and enzyme inhibition (Applied and Environmental Microbiology, 2005). While highly effective as broad-spectrum disinfectants or topical agents, the lack of specificity between bacterial and human protein thiols often limits their systemic therapeutic use due to potential host toxicity (Journal of Biological Chemistry, 2008). These groups are also involved in metal ion coordination, which can be exploited by toxic metals to disrupt bacterial metabolism (Biometals, 2011).
Drugs targeting bacterial protein thiol groups typically act through covalent modification, oxidation, or coordination with metal ions. This leads to the inactivation of essential enzymes, disruption of metabolic pathways, and loss of structural integrity of proteins, ultimately resulting in bacterial cell death.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial protein thiol group.